Ginkgo Bioworks Holdings, Inc.·4

Jun 15, 5:04 PM ET

Fubini Ross 4

4 · Ginkgo Bioworks Holdings, Inc. · Filed Jun 15, 2026

Research Summary

AI-generated summary of this filing

Updated

Ginkgo Bioworks (DNA) Director Fubini Ross Receives 25,000 RSUs

What Happened

  • Fubini Ross, a non-employee director of Ginkgo Bioworks Holdings, Inc. (DNA), was granted 25,000 restricted stock units (RSUs) on June 11, 2026. The award is reported as a derivative acquisition (code A) and no per-share price is reported (N/A) because RSUs are compensation, not an open-market trade.
  • These RSUs represent a contingent right to receive one share of the issuer’s Class A common stock per unit upon vesting. This is a compensation grant rather than a purchase or sale.

Key Details

  • Transaction date: 2026-06-11; Filing date (Form 4): 2026-06-15 (filed within the typical 2-business-day window).
  • Instrument: 25,000 Restricted Stock Units (RSUs); price: N/A (compensation award).
  • Shares owned after transaction: Not specified in the provided filing details.
  • Footnotes:
    • F1 — Each RSU converts to one share of Class A common stock upon settlement.
    • F2 — RSUs vest on the earlier of June 11, 2027 or the day immediately before the next Annual Meeting after the grant date, contingent on Ross continuing service as a non-employee director.
  • Transaction code: A = Award/Grant (derivative).

Context

  • RSU grants to directors are routine compensation and do not transfer stock ownership until vesting/settlement, so they do not indicate an immediate buy or sell decision.
  • For retail investors, director RSU grants are useful to monitor for future insider holdings but should not be interpreted as an immediate market signal.

Insider Transaction Report

Form 4
Period: 2026-06-11
Fubini Ross
Director
Transactions
  • Award

    Restricted Stock Units

    [F1][F2]
    2026-06-11+25,00025,000 total
    Class A Common Stock (25,000 underlying)
Footnotes (2)
  • [F1]Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock.
  • [F2]In accordance with the Issuer's Amended and Restated Non-Employee Director Compensation Program, which became effective on June 11, 2026, the RSUs shall vest on the earlier of June 11, 2027 or the day immediately prior to the date of the next Annual Meeting occurring after the date of grant, in either case, subject to the Reporting Person continuing in service as a Non-Employee Director through such vesting date.
Signature
/s/ Karen Tepichin, Attorney-in-Fact|2026-06-15

Documents

1 file
  • 4
    wk-form4_1781557473.xmlPrimary

    FORM 4